• 1
    Østerud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 52604.
  • 2
    Nemerson Y. The reaction between bovine brain tissue factor and factors VII and X. Biochemistry 1966; 5: 6018.
  • 3
    Giansily-Blaizot M, Aguilar-Martinez P, Biron-Andreani C, Jeanjean P, Igual H, Schved J-F, and The Study Group of Factor Seven Deficiency. Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency. Eur J Hum Genet 2001; 9: 10512.
  • 4
    Mustard JF, Secord D, Hoeksema TD, Downie HG, Rowsell HC. Canine factor-VII deficiency. Br J Haematol 1962; 8: 437.
  • 5
    Capel-Edwards K, Hall DE. Factor VII deficiency in the Beagle dog. Lab Anim 1968; 2: 10512.
  • 6
    Spurling NW, Burton LK, Peacock R, Pilling T. Hereditary factor-VII deficiency in the Beagle. Br J Haematol 1972; 23: 5967.
  • 7
    Wheeler SL, Weingand KW, Thrall MA, Berg RJ, Schwarz PD, Olson PN. Persistent uterine and vaginal hemorrhage in a Beagle with factor VII deficiency. J Amer Vet Med Assoc 1984; 185: 4478.
  • 8
    Macpherson R, Scherer J, Ross ML, Gentry PA. Factor VII deficiency in a mixed breed dog. Can Vet J 1999; 40: 5035.
  • 9
    Rhodewald MP, Weilenmann R, Griot-Wenk ME. Evaluation of a Beagle breeding colony for coagulation factor VII deficiency with the aim to eliminate affected dogs and analysis of the mode of inheritance. Thesis, Switzerland: University of Bern, 1996.
  • 10
    Margaritis P, Arruda VR, Aljamali M, Camire RM, Schlacterman A, High KA. Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII. J Clin Invest 2004; 113: 102531.
  • 11
    Rezaie AR, Esmon CT. The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives. J Biol Chem 1992; 267: 261049.
  • 12
    Toso R, Pinotti M, High KA, Pollak ES, Bernardi F. A frequent human coagulation factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor, and substrates. Biochem J 2002; 363: 4116.
  • 13
    Breen M, Jouquand S, Renier C, Mellersh CS, Hitte C, Holmes NG, Chéron A, Suter N, Vignaux F, Bristow AE, Priat C, McCann E, Andre C, Boundy S, Gitsham P, Thomas R, Bridge WL, Spriggs HF, Ryder EJ, Curson A, Sampson J, Ostrander EA, Binns MM, Galibert F. Chromosome-specific single-locus FISH probes allow anchorage of an 1800-marker integrated radiation-hybrid/linkage map of the domestic dog genome to all chromosomes. Genome Res 2001; 11: 178495.
  • 14
    McVey JH, Boswell E, Mumford AD, Kemball-Cook G, Tuddenham EGD. Factor FVII deficiency and the FVII mutation database. Hum Mutat 2001; 17: 317.
  • 15
    Mischke R. Optimization of coagulometric tests that incorporate human plasma for determination of coagulation factor activities in canine plasma. Am J Vet Res 2001; 62: 6259.
  • 16
    Hunault M, Arbini AA, Carew JA, Peyvandi F, Bauer KA. Characterization of two naturally occurring mutations in the second epidermal growth factor-like domain of factor VII. Blood 1999; 93: 123744.
  • 17
    Kavlie A, Orning L, Grindflek A, Stormorken H, Prydz H. Characterization of a factor VII molecule carrying a mutation in the second epidermal growth factor-like domain. Thromb Haemost 1998; 79: 113643.
  • 18
    Kemball-Cook G, Johnson DJD, Takamuya O, Banner DW, McVey JH, Tuddenham EGD. Coagulation factor VII Gln100[RIGHTWARDS ARROW] Arg amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant function. J Biol Chem 1998; 273: 851621.
  • 19
    Gomez K, Laffan MA, Kemball-Cook G, Pasi J, Layton M, Singer JD, Tuddenham EGD, McVey JH. Two novel mutations in severe factor VII deficiency. Br J Haematol 2004; 126: 10510.
  • 20
    Rivard GE, Brummel-Ziedins KE, Mann KG, Fan L, Hofer A, Cohen E. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thromboelastography. J Thromb Haemost 2005; 3: 203943.
  • 21
    Withnall E, Giger U. Effects of recombinant human activated factor VII and canine fresh frozen plasma in Beagles with hereditary coagulation FVII deficiency [abstract]. J Vet Intern Med 2006; 20: 766.